(Q41579674)

4 October 2017

1 reference

title

On the growth rates of human malignant tumors: implications for medical decision making (English)

1 reference

4 October 2017

On the growth rates of human malignant tumors: Implications for medical decision making (English)

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

13 November 2024

1 reference

S. Friberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9274795

13 November 2024

S. Mattson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9274795

13 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9274795

13 November 2024

publication date

1 August 1997

1 reference

4 October 2017

August 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9274795

full work available at URL

13 November 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

13 November 2024

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Journal of Surgical Oncology

13 November 2024

published in

1 reference

4 October 2017

volume

65

1 reference

4 October 2017

issue

4

1 reference

4 October 2017

page(s)

284-297

1 reference

The study by graphical analysis of the growth of human tumours and metastases of the lung

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199708%2965%3A4%3C284%3A%3AAID-JSO11%3E3.0.CO%3B2-2

Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199708%2965%3A4%3C284%3A%3AAID-JSO11%3E3.0.CO%3B2-2

The growth rate of human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199708%2965%3A4%3C284%3A%3AAID-JSO11%3E3.0.CO%3B2-2

Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199708%2965%3A4%3C284%3A%3AAID-JSO11%3E3.0.CO%3B2-2

Tumor growth rate and prognosis of breast cancer mainly detected by mass screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199708%2965%3A4%3C284%3A%3AAID-JSO11%3E3.0.CO%3B2-2

Relation between the pathological nature and the growth rate of human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199708%2965%3A4%3C284%3A%3AAID-JSO11%3E3.0.CO%3B2-2

Survival gain and volume gain. Mathematical tools in evaluating treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199708%2965%3A4%3C284%3A%3AAID-JSO11%3E3.0.CO%3B2-2

Breast cancer: the long latent interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199708%2965%3A4%3C284%3A%3AAID-JSO11%3E3.0.CO%3B2-2

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199708%2965%3A4%3C284%3A%3AAID-JSO11%3E3.0.CO%3B2-2

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

21 January 2018

1

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

The origin and development of human tumors studied with cell markers

13 November 2024

4

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth rates and responses to treatment in human myelomatosis

13 November 2024

5

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Immunocytoma o' mice an' men.

13 November 2024

6

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction

13 November 2024

7

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Clonal origin of bladder cancer

13 November 2024

8

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis

13 November 2024

9

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma

13 November 2024

11

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Origin of adult male mediastinal germ-cell tumours

13 November 2024

12

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Cell loss as a factor in the growth rate of human tumours

13 November 2024

13

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Cell loss in malignant tumours in man

13 November 2024

14

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

A biomathematical approach to clinical tumor growth

13 November 2024

16

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

The rate of growth and apparent duration of untreated primary bronchial carcinoma

13 November 2024

18

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

The frequency distribution of the rates of growth and the estimated duration of primary pulmonary carcinomas

13 November 2024

19

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

RATES OF GROWTH OF PULMONARY METASTASES AND HOST SURVIVAL

13 November 2024

20

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth rate and radiosensitivity of human tumours. I. Growth rate of human tumours

13 November 2024

22

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth rate and radiosensitivity of human tumours. II. Radiosensitivity of human tumours

13 November 2024

23

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

The concept and significance of growth rates in human pulmonary tumors

13 November 2024

26

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth Rate Investigation and Tumor Lethal Dose in Ewing's Sarcoma

13 November 2024

28

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Breast cancer--influence of growth rate on prognosis and treatment evaluation: a study based on mastectomy scar recurrences

13 November 2024

29

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth rate of 147 mammary carcinomas

13 November 2024

32

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth rate of pulmonary metastases from soft tissue sarcoma

13 November 2024

33

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

On the Nature of the Function Expressive of the Law of Human Mortality, and on a New Mode of Determining the Value of Life Contingencies

13 November 2024

35

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

The Gompertz Curve as a Growth Curve

13 November 2024

36

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Analysis of tumor growth curves

13 November 2024

38

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

13 November 2024

40

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Progress and Perspectives in the Chemotherapy of Acute Leukemia

13 November 2024

43

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth of testicular neoplasm lung metastases: Tumor-specific relation between two Gompertzian parameters

13 November 2024

44

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Observations on the growth rate of renal cell carcinoma

13 November 2024

46

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

The gross rates of growth of human mammary carcinoma

13 November 2024

47

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Age-dependent growth rate of primary breast cancer

13 November 2024

48

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population

13 November 2024

50

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

A roentgenographic study of the growth rate of 6 early cancers of the breast

13 November 2024

51

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

ROENTGENOGRAPHY OF BREAST CANCER MODERATING CONCEPT OF "BIOLOGIC PREDETERMINISM"

13 November 2024

53

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Observations on growth rate of breast carcinomas and its possible implications for lead time

13 November 2024

55

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth rates of primary breast cancers

13 November 2024

56

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Relation between mammary cancer growth kinetics and the intervals between screenings

13 November 2024

57

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

The association of pathologic and mammographic characteristics of primary human breast cancers with "slow" and "fast" growth rates and with axillary lymph node metastases

13 November 2024

60

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

What is breast cancer doing before we can detect it?

13 November 2024

61

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Prognostic Significance of the Growth Rate of Breast Cancer: Preliminary Evaluation on the Follow-Up of 196 Breast Cancers

13 November 2024

62

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Tumor doubling time and survival of men with bronchogenic carcinoma

13 November 2024

63

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth rates of small cell bronchogenic carcinomas

13 November 2024

67

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Growth rate of pulmonary metastases in human sarcomas

13 November 2024

70

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Curability of breast cancer

13 November 2024

77

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

The treatment of Wilms's tumor

13 November 2024

78

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Recurrences of cerebellar astrocytomas: a violation of Collins' law.

13 November 2024

80

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Medulloblastoma and Collins' law: a critical review of the concept of a period of risk for tumor recurrence and patient survival

13 November 2024

81

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

The curability of breast cancer

13 November 2024

83

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the Cancer Registry of Norway.

13 November 2024

84

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Long-term survival of 458 young breast cancer patients

13 November 2024

85

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

13 November 2024

Cured of breast cancer?

86

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy

13 November 2024

87

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Metastatic testicular cancer and extragonadal germ cell tumor presenting with neurological symptoms

13 November 2024

88

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Rates of growth of human solid neoplasms: Part I.

13 November 2024

89

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Rates of growth of human neoplasms: Part II.

13 November 2024

90

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma

13 November 2024

92

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Screening mammography and public health policy: the need for perspective

13 November 2024

95

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Screening for lung cancer

13 November 2024

96

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Medical and legal implications of screening and follow-up procedures for breast cancer

13 November 2024

98

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

Renal cell carcinoma: long-term survival and late recurrence

13 November 2024

99

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

5-year cure rate: Yet another myth

13 November 2024

101

1 reference

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

https://api.crossref.org/works/10.1002/(SICI)1096-9098(199708)65:4%3C284::AID-JSO11%3E3.0.CO;2-2

13 November 2024

Identifiers

10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2

1 reference

4 October 2017

1 reference